← Back to Tru in the News
PT
Pharmaceutical Technology
September 2026
FDA's IND Pilot Puts CMC Review First
Pharmaceutical Technology examines the FDA's IND pilot and its decision to put CMC review first. The article looks at what that shift in sequence could mean for sponsors preparing to enter the clinic.
Read the full article on Pharmaceutical TechnologyMore from Tru in the News
View allMC
Manufacturing Chemist
ARPA-H SURPASS Programme Targets Phaseless Clinical Trials
October 2026
CTA
Clinical Trials Arena
OCT SoCal 2026: Sound governance and collaboration lead the way as regulation percolates
October 2026
BI
BioProcess International
FDA Rolls Out Expedited Pilot Program to Address Bottlenecks in Clinical Trials
October 2026